A fast and sensitive absolute quantification assay for the detection of SARS-CoV-2 peptides using parallel reaction monitoring mass spectrometry
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2022.03.18.22272462: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Experimental Models: Cell Lines Sentences Resources SARS-CoV-2 Spike Glycoprotein (Full-Length) expressed in CHO cells from Native Antigen, Synthetic Sputum from LGC and PolyQuant Cov-MS from PolyQuant were received as part of the Covid Moonshot Consortium. CHOsuggested: CLS Cat# 603479/p746_CHO, RRID:CVCL_0213)Software and Algorithms Sentences Resources MaxQuant 1.6.10.43 was used for peptide and protein identification [20] using UniprotKB/Swissprot databases for Homo Sapiens containing 42437 sequences downloaded on September 2020 and a combined viral database SARS and influenza viruses including the SARS-Cov-2 virus sequences. Unipro…SciScore for 10.1101/2022.03.18.22272462: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Experimental Models: Cell Lines Sentences Resources SARS-CoV-2 Spike Glycoprotein (Full-Length) expressed in CHO cells from Native Antigen, Synthetic Sputum from LGC and PolyQuant Cov-MS from PolyQuant were received as part of the Covid Moonshot Consortium. CHOsuggested: CLS Cat# 603479/p746_CHO, RRID:CVCL_0213)Software and Algorithms Sentences Resources MaxQuant 1.6.10.43 was used for peptide and protein identification [20] using UniprotKB/Swissprot databases for Homo Sapiens containing 42437 sequences downloaded on September 2020 and a combined viral database SARS and influenza viruses including the SARS-Cov-2 virus sequences. UniprotKB/Swissprotsuggested: NoneResults from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-